Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: A pilot study

Journal of Biological Regulators and Homeostatic Agents

Volumn 29, Issue 4, 2015, Pages 913-923

  Rago, R ^a   Marcucci, I ^b   Leto, G ^c   Caponecchia, L ^b   Salacone, P ^b   Bonanni, P ^b   Fiori, C ^b   Sorrenti, G ^b   Sebastianelli, A ^b  

^a SANDRO PERTINI HOSPITAL   (Italy)

^b SANTA MARIA GORETTI HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alpha lipoic acid; ICSI cycles; Insulin resistance; Myo inositol; Oocyte quality; Polycistic ovarian syndrome

Indexed keywords

INOSITOL; INSULIN; THIOCTIC ACID;

ADULT; ARTICLE; BODY MASS; COMBINATION DRUG THERAPY; EMBRYO; ENDOCRINE SYSTEM; FEMALE; HUMAN; HUMAN CELL; IN VITRO FERTILIZATION; INSULIN LEVEL; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; METABOLISM PARAMETERS; MONOTHERAPY; OOCYTE; OPEN STUDY; OVARY; OVARY POLYCYSTIC DISEASE; PREGNANCY RATE; PROSPECTIVE STUDY; SPONTANEOUS ABORTION; ULTRASOUND; ADOLESCENT; BLOOD; DRUG EFFECTS; FERTILIZATION IN VITRO; PATHOPHYSIOLOGY; PILOT STUDY; PREGNANCY;

ADOLESCENT; ADULT; FEMALE; FERTILIZATION IN VITRO; HUMANS; INOSITOL; INSULIN; OOCYTES; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; THIOCTIC ACID;

EID: 84965092148     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1988; 83:3078-82.
2. Calogero AE, Calabro V, Catanuso M, Condorelli RA, La Vignera S. Understanding polycystic ovarian syndrome pathogenesis:an updated of its genetic aspects. J Endocrinol Invest 2011; 34:630-44.
3. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352:1223-36.
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607
5. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1983; 57:356-9.
6. Holte J, Bergh T, Berne C, Lithell H. Serum lipoprotein lipid profile in women with polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin Endocrinol (Oxf) 1994; 41:463-71.
7. Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996; 81:2854-64.
8. Morin-Papunen LC, Vauhkoneni I, Koivunen RM, Ruokonen A, Tapanainen JS. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum Reprod 2000; 15:1266-74.
9. Ovesen P, Moller J, Ingerslev HJ, Jorgensen JO, Mengel A, Schmitz O, Alberti KG, Moller N. Normal basal and insulin stimulated fuel metabolism in lean women with polycystic ovary syndrome. J Clin Endocrinol Metab 1993; 77:1636-40.
10. Berridge MJ. Inositol triphosphate and calcium signaling mechanisms. Biochim Biophys Acta 2009; 1793:933-40.
11. Chiu TT, Tam PP. A correlation of the outcome of clinical in vitro fertilization with the inositol content and embryotrophic properties of human serum. J Assist Reprod Genet 1992; 9:524-30.
12. Chiu TT, Rogers MS, Briton-Jones C, Haines C. Effects of myo-inositol on the in-vitro maturation ad subsequent development of mouse oocytes. Hum Reprod 2003; 18:408-16.
13. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci 2011; 15:509-14.
14. Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L. Myo-inositol may improve oocyte quality in intracytoplasmatic sperm injection cycles. A prospective controlled, randomized trial. Fertil Steril 2009; 91:1750-4.
15. Galletta M, Grasso S, Vaiarelli A, Roseff SJ. Byebye chiro-inositol-myo-inositol: true progress in the treatment of polycystic ovary syndrome and ovulation induction. Eur Rev Med Pharmacol Sci 2011; 15:1212-4.
16. Unfer V, Carlomagno P, Rizzo P, Raffone E, Roseff S. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective controlled, randomized trial. Eur Rev Med Pharmacol 2001; 15:452-7.
17. Masharani U, Gjerde C, Evans JL, Youngren JF, Goldfine ID. Effect of controlled-release alpha lipoic acid in lean, nondiabetic patients with polycystic ovary syndrome. J Diabetes Sci Technol 2010; 4:359-64.
18. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathway mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003; 52:1-8.
19. Gambera A, Visenzi C, Fratus C, Bugari G, Iacobello C, Scagliola P, Sartori E. Alternative insulinsensitizers (Lipoic acid and inositol) in polycystic ovary syndrome (PCOS). Giorn.It.Ost.Gin 2012; 34: 182-3.
20. Rotterdam ESHRE/ASRM - Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to policystic ovary syndrome. Fertil Steril 2004; 81:19-25.
21. Marci R, Marcucci I, Marcucci AA, et al. Hysterosalpingocontrast sonography (HyCoSy): evaluation of the pain perception, side effects and complications. BMC Med Imaging 2013; 13:28.
22. Van De Valde H, Nagy ZP, Joris H, De Vos A, Van Steirteghem AC. Effects of different hyaluronidase concentrations and mechanical procedures for cumulus cell removal on the outcome of intracytoplasmic sperm injection. Hum Reprod 1997; 12:2246-50.
23. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 2011; 26:1270-83
24. Toprak S. Yönem A, Cakir B, Guler S, Azal O, Ozata M, Corakci A. Insulin resistance in nonobese patients with polycystic ovary syndrome. Hormone Research 2001; 55:65-70.
25. Karuputhula NB, Chattopadhayay R, Chakravarty B, Chaudhury K. Oxidative status in granulose cells of infertile women undergoing IVF. Syst Biol Reprod Med 2013; 59:91-8.
26. Pantasri T, Norman RJ. The effects of being overweight and obese on female reproduction: a review. Gynecol Endocrinol 2014; 30:90-4.
27. Lord T, Aitken RJ. Oxidative stress and ageing of the post-ovulatory oocyte. Reproduction 2013; 146:R217-27.
28. Takahashi T, Igarashi H, Kawagoe J, Amita M, Hara S, Kurachi H. Poor embryo development in mouse oocytes aged in vitro is associated with impaired calcium homeostasis. Biol Reprod 2009; 80:493-502
29. Takahashi T, Takahashi E, Igarashi H, Tezuka N, Kurachi H. Impact of oxidative stress in aged mouse oocytes on calcium oscillations at fertilization. Mol Reprod Dev 2003; 66:143-52.
30. Chiu TT, Rogers MS, Law E, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod 2002; 17:1591-6.
31. Petersen SK, Moreau RF, Smith EJ, Hagen TM. Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. IUBMB Life 2008; 60:362-7.
32. Wada H, Shintani D, Ohlrogge J. Why do mitochondria synthesize fatty acids? Evidence for involvement in lipoic acid production. Proc Natl Acad Sci USA 1997; 94:1591-6.